Share on PinterestA brand new experimental weight reduction drug from Eli Lilly reveals dramatic outcomes that rival present GLP-1 medicine and bariatric surgical procedure. Picture Credit score: Scott Olson/Getty Photos Eli Lilly lately introduced part 3 trial outcomes for a promising new weight reduction drug retatrutide. The dramatic outcomes from the TRIUMPH-1 trial signify the... Read More





:max_bytes(150000):strip_icc():format(jpeg)/hlt-biolage-scalp-sync-concentrate-7-bb80d4e243a04013894b1267f788cc81.jpeg?w=600&resize=600,400&ssl=1)


:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-802684710-4d7dee90126e44bda7928b19512d1da4.jpg?w=160&resize=160,100&ssl=1)
:max_bytes(150000):strip_icc():format(jpeg)/Shungite-48584f1aec054549a9605924ce7cb673.jpg?w=160&resize=160,100&ssl=1)


:max_bytes(150000):strip_icc()/HDC-GettyImages-668641904-9179dc9fe60446d8b4d8a08fbffcf46d.jpg?w=600&resize=600,400&ssl=1)


Recent Comments